Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer?

Lancet Oncology

Volumn 6, Issue 7, 2005, Pages 529-531

  Udelsman, Robert ^a   Shaha, Ashok R ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE; THYROID HORMONE;

ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; HIGH RISK PATIENT; HUMAN; LUNG METASTASIS; MEDICAL DECISION MAKING; MORBIDITY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RECURRENCE RISK; RISK REDUCTION; SUBTOTAL THYROIDECTOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; THYROID CANCER; THYROIDECTOMY; TREATMENT INDICATION; UNITED STATES;

EID: 21344451662     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)70247-3     Document Type: Note

References (19)

1. R Udelsman E Lakatos P Ladenson Optimal surgery for papillary thyroid carcinoma World J Surg 20 1996 88-93
2. Dackiw APB M Zeiger Extent of surgery for differentiated thyroid cancer Surg Clin North Am 84 2004 817-832
3. H Chen R Udelsman Papillary Thyroid Carcinoma. Justification for total thyroidectomy and management of lymph node metastases Surg Oncol Clin N Am 7 1998 645-663
4. OH Clark Total thyroidectomy: The treatment of choice for patients with differentiated thyroid cancer Ann Surg 196 1982 361-370
5. ID Hay WM McConahey JR Goellner Managing patients with papillary thyroid carcinoma: Insights gained from the Mayo Clinic's experience of treating 2512 consecutive patients during 1940 through 2000 Trans Am Clin Clim Assoc 113 2002 241-260
6. JP Massin JC Savoie H Garnier et al. Pulmonary metastases in differentiated thyroid carcinoma: Study of 58 cases with implications for the primary tumor treatment Cancer 53 1984 982-992
7. EL Mazzaferri SM Jhiang Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 97 1994 418-428
8. JA Sosa HM Bowman JM Tielsch et al. Importance of surgeon experience for clinical and economic outcomes from thyroidectomy Ann Surg 228 1998 320-330
9. AACE/AAES Medical/surgical guidelines for clinical practice: Management of thyroid carcinoma Endocr Pract 7 2001 203-220
10. AR Shaha Controversies in the management of thyroid nodule Laryngoscope 110 2000 183-193
11. R Udelsman E Lakatos P Ladenson Optimal surgery for papillary thyroid carcinoma World J Surg 20 1996 88-93
12. JP Shah TR Loree D Dharker EW Strong Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: A matched pair analysis Am J Surg 166 1993 331-335
13. SA Hundahl ID Fleming AM Fremgen et al. A national cancer data base report on 53856 cases of thyroid carcinoma treated in the US, 1985-1995 Cancer 83 1998 2638-2648
14. ID Hay CS Grant WF Taylor et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system Surgery 102 1987 1088-1095
15. AR Shaha Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer Laryngoscope 1114 2004 393-402
16. AR Shaha JP Shah TR Loree Low-risk differentiated thyroid cancer: The need for selective treatment Ann Surg Oncol 4 1997 328-333
17. B Cady Presidential address. Beyond the risk groups-a new look at differentiated thyroid cancer Surgery 124 1998 947-957
18. JA Sosa HM Bowman Tielsch MD et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy Ann Surg 228 1998 320-330
19. OH Clark Total thyroidectomy: The treatment of choice for patients with differentiated thyroid cancer Ann Surg 196 1982 361-370